Clinical Trial

Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver Disease

Study acronym: NAFLD-cohort
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 13, 2016 (before its estimated December 2017 completion). Its status may not reflect the trial's current state.
Summary
The aim of the present prospective NAFLD cohort study (with biobank), of obese subjects with proven NAFLD based on liver biopsy and/or MRI, is to study factors contributing to the development of NASH in patients with simple steatosis and to identify and validate non-invasive markers for the diagnosis of NASH.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2015-04-16; most recent amendment 2016-09-12.
Status change: Not Yet Recruiting → Recruiting 2015-09-08
Trial Details
NCT Number NCT02422238
Lead Sponsor Maastricht University Medical Center
Collaborators: Centrum Obesitas-Eetstoornissen (CO-EUR)
Conditions Nonalcoholic Fatty Liver Disease
Enrollment 500 participants
Start Date 2015-06
Primary Completion 2017-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2016-09-13